| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 495,3 k € | +10.9% | 446,5 k € | -9.0% | 490,5 k € | -2.5% | 503,2 k € | +17.9% | 426,8 k € | +5.4% | 404,8 k € | +25.2% | 323,3 k € | +44.2% | 224,2 k € | -6.1% | 238,8 k € | +52.8% | 156,3 k € | -16.1% | 186,4 k € | -70.7% | 636,3 k € | +26.6% | 502,7 k € | -24.2% | 663,5 k € | -6.4% | 708,6 k € | +43.1% | 495,3 k € | +9.1% | 453,8 k € | +33.3% | 340,4 k € | +39.3% | 244,5 k € | |
| EBITDA | 488,0 k € | +11.1% | 439,2 k € | -3.2% | 453,8 k € | -8.7% | 496,8 k € | +18.4% | 419,5 k € | +4.8% | 400,4 k € | +25.1% | 320,2 k € | +45.5% | 220,0 k € | -7.2% | 237,1 k € | +53.8% | 154,2 k € | -13.9% | 179,1 k € | -71.5% | 629,2 k € | +25.7% | 500,4 k € | -24.3% | 660,6 k € | -5.7% | 700,3 k € | +45.3% | 481,9 k € | +10.3% | 436,7 k € | +31.5% | 332,1 k € | +39.8% | 237,5 k € | |
| Operating profit | 448,1 k € | +15.8% | 387,1 k € | -2.7% | 398,0 k € | -9.7% | 440,9 k € | +21.9% | 361,7 k € | +4.7% | 345,4 k € | +23.4% | 279,8 k € | +52.7% | 183,2 k € | -8.0% | 199,1 k € | +61.0% | 123,6 k € | -16.3% | 147,7 k € | -74.8% | 586,1 k € | +38.7% | 422,5 k € | -27.6% | 583,3 k € | -6.1% | 620,9 k € | +56.8% | 396,0 k € | +13.2% | 349,9 k € | +39.8% | 250,2 k € | +65.8% | 150,9 k € | |
| Profit/loss | 343,2 k € | +9.4% | 313,6 k € | +2.0% | 307,5 k € | -3.6% | 319,1 k € | +6.2% | 300,4 k € | +2.0% | 294,5 k € | +18.1% | 249,3 k € | +54.0% | 161,9 k € | -12.3% | 184,7 k € | +42.6% | 129,5 k € | -82.7% | 748,7 k € | +112.1% | 353,0 k € | +26.8% | 278,5 k € | -27.2% | 382,5 k € | -2.9% | 393,8 k € | +62.2% | 242,8 k € | +13.2% | 214,4 k € | +52.5% | 140,6 k € | +58.1% | 88,9 k € | |
| Equity | 2,2 M € | -0.8% | 2,2 M € | +16.5% | 1,9 M € | -13.4% | 2,2 M € | +5.0% | 2,1 M € | +16.9% | 1,8 M € | +19.7% | 1,5 M € | +20.1% | 1,2 M € | -32.2% | 1,8 M € | +11.3% | 1,6 M € | -0.0% | 1,6 M € | +95.5% | 838,0 k € | -9.6% | 926,5 k € | +14.7% | 808,0 k € | +40.4% | 575,5 k € | +14.7% | 501,8 k € | +129.2% | 219,0 k € | -14.0% | 254,5 k € | +123.4% | 113,9 k € | |
| Total assets | 2,5 M € | +0.3% | 2,5 M € | +2.5% | 2,4 M € | -18.2% | 3,0 M € | +11.6% | 2,7 M € | +6.9% | 2,5 M € | +11.6% | 2,2 M € | +7.2% | 2,1 M € | -1.6% | 2,1 M € | -23.4% | 2,8 M € | +9.3% | 2,5 M € | +108.0% | 1,2 M € | +0.1% | 1,2 M € | +8.0% | 1,1 M € | -4.4% | 1,2 M € | +40.0% | 843,4 k € | +8.9% | 774,3 k € | +16.0% | 667,3 k € | -10.3% | 743,9 k € | |
| Cash | 520,7 k € | +50.2% | 346,7 k € | +87.7% | 184,7 k € | -74.5% | 724,2 k € | +103.4% | 356,1 k € | +143.5% | 146,3 k € | -45.0% | 265,9 k € | +140.3% | 110,7 k € | -28.8% | 155,5 k € | -3.1% | 160,4 k € | -76.9% | 695,1 k € | +157.6% | 269,9 k € | -51.3% | 554,0 k € | -6.9% | 595,1 k € | +40.3% | 424,2 k € | -7.4% | 458,2 k € | +273.1% | 122,8 k € | -8.2% | 133,7 k € | -2.8% | 137,5 k € | |
| Debts | 324,2 k € | +8.1% | 299,9 k € | -45.3% | 548,5 k € | -31.2% | 796,8 k € | +34.9% | 590,7 k € | -16.9% | 711,0 k € | -5.2% | 750,0 k € | -10.2% | 835,5 k € | +233.0% | 250,9 k € | -77.3% | 1,1 M € | +33.9% | 825,0 k € | +118.3% | 377,9 k € | +31.0% | 288,6 k € | -9.2% | 317,8 k € | -47.2% | 602,0 k € | +80.3% | 333,9 k € | -39.9% | 555,3 k € | +34.5% | 412,8 k € | -34.5% | 629,9 k € | |
| Staff | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,3 | — | |||||||||||||||||||
Private company with limited liability · Ieper · incorporated on 11/08/2000 · 0,0 ETP
Private company with limited liability profitable and well capitalised. Cash position rising (+50.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Blanckaert MD is a Private company with limited liability incorporated in 2000. Its main activity is: Specialist medical practice activities. Its registered office is in Ieper.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette